Tadalafil and Hepatic failure - a phase IV clinical study of FDA data
Summary:
Hepatic failure is reported as a side effect among people who take Tadalafil (tadalafil), especially for people who are female, 40-49 old, have been taking the drug for 1 - 2 years also take Remodulin, and have Primary pulmonary hypertension.
The phase IV clinical study analyzes which people have Hepatic failure when taking Tadalafil. It is created by eHealthMe based on reports of 25,126 people who have side effects when taking Tadalafil from the FDA, and is updated regularly.
What is Tadalafil?
Tadalafil has active ingredients of tadalafil. It is often used in erection problems. eHealthMe is studying from 25,549 Tadalafil users. Check the latest studies of Tadalafil.
What is Hepatic failure?
Hepatic failure (liver failure) is found to be associated with 1,539 drugs and 1,894 conditions by eHealthMe. Check the latest studies of Hepatic failure.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
25,126 people reported to have side effects when taking Tadalafil.
Among them, 27 people (0.11%) have Hepatic failure.

Among these 27 people:
How long have people been on Tadalafil when they have Hepatic failure? *
- < 1 month: 0.0 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 100 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Hepatic failure when taking Tadalafil? *
- female: 59.26 %
- male: 40.74 %
What is the age of people who have Hepatic failure when taking Tadalafil? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 14.29 %
- 20-29: 0.0 %
- 30-39: 9.52 %
- 40-49: 33.33 %
- 50-59: 28.57 %
- 60+: 14.29 %
What are other drugs people take besides Tadalafil? *
- Remodulin: 9 people, 33.33%
- Opsumit: 8 people, 29.63%
- Ambrisentan: 7 people, 25.93%
- Oxycodone: 5 people, 18.52%
- Tyvaso: 5 people, 18.52%
- Veletri: 5 people, 18.52%
- Eliquis: 4 people, 14.81%
- Acetaminophen: 4 people, 14.81%
- Ondansetron: 3 people, 11.11%
- Letairis: 3 people, 11.11%
What are other side effects people have besides Hepatic failure? *
- Nausea And Vomiting: 11 people, 40.74%
- Nausea (feeling of having an urge to vomit): 9 people, 33.33%
- Acute Kidney Failure: 7 people, 25.93%
- Weakness: 5 people, 18.52%
- Hypotension (abnormally low blood pressure): 5 people, 18.52%
- Fatigue (feeling of tiredness): 5 people, 18.52%
- Diarrhea: 5 people, 18.52%
- Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 4 people, 14.81%
- Hepatic Encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure): 4 people, 14.81%
- Liver Disorder (liver diseases): 4 people, 14.81%
What are the existing conditions these people have? *
- Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 18 people, 66.67%
- Pulmonary Hypertension (increase in blood pressure in the lung artery): 7 people, 25.93%
- Pain: 2 people, 7.41%
- Autoimmune Hepatitis: 2 people, 7.41%
- Wheezing (a high-pitched whistling sound made while you breath): 1 person, 3.70%
- Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 3.70%
- Portopulmonary Hypertension (coexistence of portal and pulmonary hypertension): 1 person, 3.70%
- Portal Hypertension (increase in the blood pressure within a system of veins called the portal venous system): 1 person, 3.70%
- Pain In Extremity: 1 person, 3.70%
- Nausea (feeling of having an urge to vomit): 1 person, 3.70%
* Approximation only. Some reports may have incomplete information.
Do you take Tadalafil and have Hepatic failure?
- Check whether Hepatic failure is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Tadalafil:
- Tadalafil (25,549 reports)
Hepatic failure treatments and more:
- Hepatic failure (44,058 reports)
How severe was Hepatic failure and when was it recovered:
Expand to all the drugs that have ingredients of tadalafil:
- Hepatic failure and drugs with ingredients of tadalafil (143 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Tadalafil:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Hepatic failure:
- Hepatic failure (1,539 drugs)
Browse all the conditions that are associated with Hepatic failure:
- Hepatic failure (1,894 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on tadalafil (the active ingredients of Tadalafil) and Tadalafil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Yaz cause Asthma Aggravated? - 26 seconds ago
- Could Guaifenesin cause Red Cell Distribution Width Increased? - 49 seconds ago
- Could Ocrevus cause Infusion Site Extravasation? - a minute ago
- Drug interactions of Veramyst and Zolpidem - a minute ago
- Drug interactions of Zolpidem and Eszopiclone - a minute ago
- Could Nystatin cause Extravasation Blood? - a minute ago
- Could Dexamethasone cause Stent Occlusion? - a minute ago
- Could Urso 250 cause Nephritis - Interstitial? - a minute ago
- Could Urso 250 cause Interstitial Nephritis? - a minute ago
- Imipramine Hydrochloride vs. Marplan, side effect and effectiveness comparison - a minute ago